# Arvinas, Inc. (ARVN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ARVN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 268.88M | $ -82.73M | $ 137.00M | $ 8.50M | $ 433.90M |
| 2024 | $ 276.85M | $ -209.06M | $ -236.07M | $ 9.70M | $ 561.70M |
| 2023 | $ 84.88M | $ -397.14M | $ -156.02M | $ 3.20M | $ 660.00M |
| 2022 | $ 146.90M | $ -315.58M | $ -34.30M | $ 5.50M | $ 564.90M |
| 2021 | $ 55.39M | $ -227.15M | $ -896.55M | $ 5.00M | $ 781.70M |
| 2020 | $ 27.77M | $ -152.02M | $ 94.90M | $ 4.10M | $ 642.20M |
| 2019 | $ 55.47M | $ -90.73M | $ -172.60M | $ 4.39M | $ 226.69M |
| 2018 | $ 18.92M | $ -54.78M | $ -258.57M | $ 2.15M | $ 136.67M |
| 2017 | $ 10.21M | $ -32.40M | $ 35.01M | $ 310.4K | $ 245.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.65 |
| Current Ratio | 4.92 |

## Other views

- [Metrics](https://sponda.capital/en/ARVN.md)
- [Charts](https://sponda.capital/en/ARVN/charts.md)
- [Compare](https://sponda.capital/en/ARVN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.